FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, specifically to immunology, and can be used in medicine and diagnosis of conditions in a mammal, characterized by hypersensitivity to peanuts or hazelnuts, which contain Ara h 1. Compositions of peptides are obtained by corpus epitope region Ara h 1 of T-cells.
EFFECT: invention provides desensitization or induction of immunological tolerance to Ara h 1.
24 cl, 5 dwg, 1 ex, 11 tbl
Title | Year | Author | Number |
---|---|---|---|
NOVEL IMMUNOTHERAPEUTIC COMPOSITION AND USE THEREOF | 2014 |
|
RU2689552C2 |
IMMUNE MODULATION | 2014 |
|
RU2709771C2 |
IMMUNE MODULATION | 2014 |
|
RU2662927C2 |
HYBRID PEPTIDE CARRYING PROTEINS AS VACCINES AGAINST ALLERGY | 2012 |
|
RU2630652C2 |
NEW IMMUNOGENIC PEPTIDES | 2015 |
|
RU2709711C2 |
MILK MIXTURE WITH SPECIFIC PEPTIDES OF BETA-LACTOGLOBULIN | 2019 |
|
RU2780747C2 |
EPITOPIC PEPTIDES RAB6KIFL/KIF20A AND VACCINES CONTAINING THEM | 2009 |
|
RU2532105C2 |
HJURP PEPTIDES AND VACCINES CONTAINING THEM | 2011 |
|
RU2570560C2 |
CDC45L PEPTIDES AND VACCINES CONTAINING SAME | 2010 |
|
RU2562160C2 |
PEPTIDE | 2014 |
|
RU2667428C2 |
Authors
Dates
2019-05-07—Published
2013-10-30—Filed